Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

A sequential and synergistic release sacrificial microgels scaffold for endometrial niche reprogramming and fertility restoration.

Liu Q., Lu S., Zhou J., Xu J., Shao J., Zheng J.

Laboratory Study on Chronic Inflammation, published in Mater Today Bio (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Mater Today Bio (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42205194
PMCID
PMC13202539
DOI
10.1016/j.mtbio.2026.103235

Abstract (original English)

Intrauterine adhesions (IUA) remain a therapeutic challenge, necessitating advanced regenerative strategies. Herein, we propose a "programmed endometrial niche" strategy, a 3D-printed adipose-derived stem cells (ADSCs) hydrogel scaffold is constructed via microfluidic technology, incorporating platelet-rich plasma (PRP)-loaded thermosensitive gelatin microgels (PMS@AH) for sequential and synergistic delivery of PRP and ADSCs to restore the endometrial immune microenvironment and niche. In vitro assays demonstrate that PMS@AH possesses excellent biocompatibility and significantly promoted cell proliferation, migration, and angiogenesis, accompanied by potent anti-inflammatory activity. In both rat and cynomolgus macaque IUA models, it effectively restored endometrial structure, reduced fibrosis and inflammation, and successfully restored fertility. Mechanistically, RNA-sequencing analysis reveals that PMS@AH involves suppressing the IL-17/nuclear factor-κB (NF-κB) pathway to modulate the immune microenvironment and inhibiting the Wnt/β-catenin pathway to program the endometrial niche. This sequentially releasing scaffold presents a promising platform for treating IUA and broader applications in reproductive medicine.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research